
🗞️ Karyopharm, maker of Selinexor, filed Chapter 11 today and plans to merge with Ayrmid. It says its MF program continues, and the deal should close Q1 2027. FDA acceptance of selinexor plus rux for MF is still pending. - prnewswire.com/news-releases… #MPN #Myelofibrosis








